Equistone-backed Concept Life Sciences acquires Aquila BioMedical

Concept Life Sciences, which is backed by Equistone Partners Europe, has acquired Edinburgh-based Aquila BioMedical, a pre-clinical contract research company with expertise in immuno-oncology, immunology and multiplex histology. No financial terms were disclosed.

DealsNorth AmericaUSHealthcareBriefs